Lorenzo Malatino

Full Professor of INTERNAL MEDICINE [MED/09]

Time acting as staff-member at University of Catania: 1978-present. 
Full Professor of Internal Medicine from March 2007-present, Chair of Internal Medicine, Director Hypertension Centre, University of Catania. 
Associate Professor of Medicine from 2001 to 2007; 
Assistant Professor of Medicine from 1978 to 2000.

Stage in International qualified Centres: MRC Blood Pressure Unit, Western Infirmary, Glasgow, UK, (1983-85).

Director of Academic Unit of Internal Medicine, University of Catania, Italy, (from January 2004 to date).

Director Postgraduate school of Internal Medicine University of Catania, Italy, (2009-2012).

Director International PhD program Translational Biomedicine, University of Catania, Italy (2013-present).

Director Master in Emergency Medicine University of Catania, Italy (2012-present).

Teaching: Internal Medicine; Pathophysiology and Semeiotics (School of Medicine); Cardiology (Postgraduate School of Internal Medicine); Emergency in Sports Medicine (Postgraduate School of Sports medicine); Internal Medicine (Postgraduate School of Cardiology).

Research Lines: Cardiovascular Risk in hypertension and end stage renal disease; Congestive heart failure; Intervention trials on cardio-renal damage in hypertension. Natriuretic Peptides as markers and therapeutic target for management of patients with cardiovascular diseases. Venous Thrombo-embolism (Scores for Deeps Venous Thrombosis and Pulmonary Embolism). Cardiovascular dam-age in metabolic diseases.

National and International Partnerships: CNR-IBIM U.O.C. Nefrologia (Prof. C. Zoccali), Reggio Calabria, Italy; Cardiorenal Research Laboratory, Mayo Clinic, Rochester, Minnesota, USA (Prof. J.C. Burnett Jr.); Department of Clinical Pharmacology, Edinburgh University, UK (Prof. D.J. Webb). 

International Nominations: Hypertension Specialist (European Society of Hypertension); Member of International Society of Hypertension, European Society of Hypertension. Visiting Scientist at Mayo School of Medicine, Rochester, Minnesota, USA from 2006 to date). 

Referee of ranked Journals: Stroke; American Journal of Kidney Diseases;  Journal of  Nephrolo-gy; Life Sciences; Nutrition Metabolism & Cardiovascular Disease; J Applied Physiology, Nutrition Metabolism and Cardiovascular Disease (NMCD), American Journal of Physiology-Renal, Ameri-can Journal of Physiology-Cell Physiology, American Journal of Physiology-Heart and Circulatory Physiology, Trends in Cardiovascular Medicine, Nephrology Dialysis and Transplantation, Journal of American Society of Nephrology, Hypertension, Peritoneal Dialysis International, Open Hyper-tension Journal, Aging (Albany,USA), PLoS ONE.

Membership Adivisory Board: Open Hypertension Journal. ISRN Cardiology, Journal of Internal and Translational Medicine.

Membership of Editorial Board: Ipertensione e Prevenzione Cardiovascolare (official Journal of Italian Society of Hypertension); 

Academic Editor: International Journal of Molecular Science.

Referee of ANVUR (from 2004-2010) for the evaluation of research quality in Italy (GEV for VQR); PRIN and CIVR.

Member of the Italian Council for evaluation of candidates for professorship in Internal Medicine in Italy (2012-2016). 

Membership of Societies'Committees: 1997-99 Sezione Siculo-Calabra Società Italiana Ipertensio-ne; 2001-2005 Società Italiana Ipertensione; 2005-2007 Sezione Interregionale Siculo-Calabra So-cietà Italiana Studio Aterosclerosi, 2007-2013: Sezione Interregionale Siculo-Calabra Società Italia-na Medicina Interna; 2007-2008: President of Sezione Interregionale Siculo-Calabra Sociatà Italiana dell'Ipertensione Arteriosa.

Membership of Scientific Societies 
International Society of Hypertension, European Society of Hypertension, Italian Society of Hyper-tension, Italian Society of Internal Medicine. 

Publications: more than 200, including original papers and chapters (Total IF 880) Hirsch index 39 (Scopus), N. of citations 7256 (Scopus).


N.B. the number of publications can affect the loading time of the information

Academic Year 2021/2022

Academic Year 2020/2021

Academic Year 2019/2020

Academic Year 2018/2019

Academic Year 2017/2018

Academic Year 2016/2017

Academic Year 2015/2016

Cardiovascular Risk in hypertension and end stage renal disease.
Congestive heart failure.
Interven-tion trials on cardio-renal damage in hypertension. 
Natriuretic Peptides as markers and therapeutic target for management of patients with cardiovascular diseases. 
Venous Trhromboembolism (Scores for Deeps Venous Thrombosis and Pulmonary Embolism). 
Cardiovascular damage in metabolic diseases. 


Meeting organization in the field of cardiovascular and renal risk for specialists and medical practitioners

Directorship Master Emergency Medicine and PhD Program In Translational biomedicine, University of Catania.